The Zhitong Finance App learned that as of press release,$Dongguang Pharmaceutical (01558.HK) $It surged more than 9%, and rose more than 30% during the month.

According to the news, recently, national influenza surveillance information released by the National Influenza Center shows that since June, some southern provinces have entered a period of high influenza incidence, and the proportion of influenza-like cases in outpatient clinics has continued to increase. The number of influenza cases has reached a new high for the same period in recent years.

The report said that as the number of visits to fever clinics continued to rise, oseltamivir was out of stock in many places. According to reports, Dongguang Pharmaceutical is the main manufacturer of oseltamivir generic drugs in China. Relevant sources from Dongguang Pharmaceutical said that the company is currently in a state of full production and sales, and is also actively making production adjustments to prepare sufficient stocks to cope with the current influenza outbreak.